The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma

BACKGROUND: Recent preclinical studies identified Axl, a tyrosine kinase receptor implicated in tumour progression and epithelial-to-mesenchymal transition, as a putative therapeutic target in malignant pleural mesothelioma (MPM), an invariably fatal malignancy with limited treatment options. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, D J, Mauri, F A, Lloyd, T, Vaira, V, Casadio, C, Boldorini, R L, Sharma, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593571/
https://www.ncbi.nlm.nih.gov/pubmed/23361052
http://dx.doi.org/10.1038/bjc.2013.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593571/
https://www.ncbi.nlm.nih.gov/pubmed/23361052
http://dx.doi.org/10.1038/bjc.2013.9

Ejemplares similares